We're urging the court to uphold the FDA’s Final Marketing Denial Order because their decision was supported by evidence showing that the harm to the public, especially youth, was greater than the evidence provided by the company that their flavored nicotine product assisted smoking cessation more than unflavored products.
Medical groups support the FDA’s denial as it protects the public, including minors, from marketing that entices use of electronic tobacco products without appreciation of the harm they cause. Both OSMA and the AMA consistently advocate against tobacco use and have policy against use of e-cigarettes and electronic nicotine delivery system (ENDS) devices, especially flavored nicotine products.